Solio Therapy

RF Energy-based Solutions for Pain Relief

Health Tech & Life Sciences
Active
Mature Herzliya Founded 2001
Total raised
Stage
Mature
Founded
2001
Headcount
1
HQ
Herzliya
Sector
Health Tech & Life Sciences

About

Solio Therapy offers advanced technologies for pain relief and therapy treatments. Its technologies are packed in small, user-friendly, affordable devices designed for safe home use. The company's new device, the Solio Alfa Plus, is an FDA- and CE-approved radio frequency (RF) home device for pain relief. Solio Alfa Plus is meant to help relieve chronic pain and pain from trauma, sports injury, and menstruation. When placed on the part of the body that hurts, four RF diodes non-invasively penetrate the skin with deep heat to increase blood circulation; accelerate tissue regeneration; and reduce inflammation, muscle aches, stiffness, and pain. The product is manufactured in northern Israel by Flextronics. The Solio Therapy technology was commercialized by DMT, a privately funded company based in Herzliya. DMT was founded to commercialize the invention along with an Israeli medical company located in Yokne'am.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Solio Therapy's primary focus?
Solio Therapy specializes in RF energy-based solutions for pain relief, offering advanced technologies packed in small, user-friendly devices for home use.
When was Solio Therapy founded?
Solio Therapy was founded in December 2001.
What is Solio Therapy's main product?
Solio Therapy's main product is the Solio Alfa Plus, an FDA- and CE-approved radio frequency (RF) home device designed for pain relief.
What conditions does the Solio Alfa Plus device address?
The Solio Alfa Plus device is intended to help relieve chronic pain and pain resulting from trauma, sports injuries, and menstruation.
Where is the Solio Alfa Plus product manufactured?
The Solio Alfa Plus product is manufactured in northern Israel by Flextronics.
When did Solio Therapy's Alfa Plus device receive FDA clearance?
In July 2019, the Alfa Plus by Solio received FDA clearance.
Who commercialized Solio Therapy's technology?
Solio Therapy's technology was commercialized by DMT, a privately funded company based in Herzliya, in collaboration with an Israeli medical company located in Yokne'am.
Who is a founder of Solio Therapy?
Chuck (Shahak) Cohen is a founder of Solio Therapy.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Sensing
Target customers
Healthcare & Life SciencesHealthcarePatients
Business model
B2C

Highlights

Verified

Tags

rf-technologypatientsanti-aginghome-caredermatologymedical-technologiesmedical-devicesskin-carenon-invasiveacnechronic-painwomen-healthpain-reliefwomenmedical-products